Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway

Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway

Background/Aims: Qiliqiangxin (QL) has been used for the treatment of chronic heart failure in China. Accumulating evidence suggests QL's cardio-protective effects on continuous myocardial ischemia. However, it is unclear whether QL has beneficial effects on cardiac ischemia-reperfusion (I/R) i...

Full description

Bibliographic Details
Main Authors: Yonglan Zhou, Hongyi Fang, Shenghui Lin, Shutong Shen, Lichan Tao, Junjie Xiao, Xinli Li
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2015-08-01
Series:Cellular Physiology and Biochemistry
Subjects:
Qiliqiangxin
Cardiac ischemia-reperfusion injury
mTOR
Online Access:http://www.karger.com/Article/FullText/430368

Similar Items

Similar Items